Table 1.
Total (n = 203) | PF (n = 67) | AF (n = 70) | WL (n = 66) | pb | |||||
---|---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | n | % | ||
Partners’ characteristics | |||||||||
Gender (n = 203) | .974 | ||||||||
Female | 143 | 70.4 | 47 | 70.1 | 50 | 71.4 | 46 | 69.7 | |
Male | 60 | 29.6 | 20 | 29.9 | 20 | 28.6 | 20 | 30.3 | |
Age, mean (SD), years [range] (n = 203) |
55.89 (10.72) [27–82] |
56.97 (9.88) [29–82] |
56.40 (11.15) [30–79] |
54.24 (11.03) [27–79] |
.251 | ||||
Country of birth (n = 203) | .177 | ||||||||
The Netherlands | 193 | 95.1 | 61 | 91.0 | 68 | 97.1 | 64 | 97.0 | |
Other | 10 | 4.9 | 6 | 9.0 | 2 | 2.9 | 2 | 3.0 | |
Children (n = 203) | .240 | ||||||||
No/or living away from home | 131 | 64.5 | 43 | 64.2 | 50 | 71.4 | 38 | 57.6 | |
Yes, living at home | 72 | 35.5 | 24 | 35.8 | 20 | 28.6 | 28 | 42.4 | |
Education (n = 197) | .065 | ||||||||
Low | 32 | 16.2 | 6 | 9.0 | 14 | 20.0 | 12 | 18.2 | |
Middle | 58 | 29.4 | 19 | 28.4 | 25 | 35.7 | 14 | 21.2 | |
High | 107 | 54.3 | 41 | 61.2 | 28 | 40.0 | 38 | 57.6 | |
Employment (n = 203) | .184 | ||||||||
Paid job | 121 | 59.6 | 41 | 61.2 | 36 | 51.4 | 44 | 66.7 | |
No job | 82 | 40.4 | 26 | 38.8 | 34 | 48.6 | 22 | 33.3 | |
Patients’ cancer-related characteristics | |||||||||
Sort of cancer (n = 199) | .254 | ||||||||
Colon cancer | 28 | 14.1 | 8 | 11.9 | 7 | 10 | 13 | 19.7 | |
Prostate cancer | 24 | 12.1 | 5 | 7.5 | 12 | 17.1 | 7 | 10.6 | |
Lung cancer | 23 | 11.6 | 5 | 7.5 | 9 | 12.9 | 9 | 13.6 | |
Breast cancer | 18 | 9.0 | 8 | 11.9 | 8 | 11.4 | 2 | 3.0 | |
Lymph node cancer | 17 | 8.5 | 9 | 13.4 | 5 | 7.1 | 3 | 4.5 | |
Head and neck cancer | 11 | 5.5 | 5 | 7.5 | 3 | 4.3 | 3 | 4.5 | |
Leukemia | 11 | 5.5 | 6 | 9.0 | 1 | 1.4 | 4 | 6.1 | |
Bone marrow cancer | 11 | 5.5 | 4 | 6.0 | 3 | 4.3 | 4 | 6.1 | |
Brain tumor | 8 | 4.0 | 1 | 1.5 | 4 | 5.7 | 3 | 4.5 | |
Kidney cancer | 8 | 4.0 | 1 | 1.5 | 4 | 5.7 | 3 | 4.5 | |
Othera | 40 | 20.1 | 15 | 22.4 | 13 | 18.6 | 12 | 18.2 | |
Time since diagnosis (n = 203) | .600 | ||||||||
Between 3 and 6 months ago | 43 | 21.2 | 13 | 19.4 | 12 | 17.1 | 18 | 27.3 | |
Between 6 and 12 months ago | 47 | 23.2 | 15 | 22.4 | 18 | 25.7 | 14 | 21.2 | |
1–5 years ago | 81 | 39.9 | 28 | 41.8 | 27 | 38.6 | 26 | 39.4 | |
5–10 years ago | 19 | 9.4 | 6 | 9.0 | 10 | 14.3 | 3 | 4.5 | |
> 10 years ago | 13 | 6.4 | 5 | 7.5 | 3 | 4.3 | 5 | 7.6 | |
Current treatment (n = 201) | .982 | ||||||||
No | 78 | 38.8 | 26 | 38.8 | 27 | 38.6 | 25 | 37.9 | |
Yes | 123 | 61.2 | |||||||
Self-reported phase of disease (n = 203) | .995 | ||||||||
Patient is still in treatment with curative intent | 52 | 25.6 | 17 | 25.4 | 18 | 25.7 | 17 | 25.8 | |
Treatment with curative intent is completed; patient is recovered | 33 | 16.3 | 12 | 17.9 | 11 | 27.5 | 10 | 15.2 | |
Patient will (probably) not recover | 118 | 58.1 | 38 | 56.7 | 41 | 58.6 | 39 | 59.1 |
PF, personal feedback; AF, automatic feedback; WL, waiting list
a17 different sorts of cancer
bOne-way ANOVA for age, chi-square tests for the remaining variables